Skip to main content

Abiomed Inc

ABMDDelisted Dec 22, 2022
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000815094

Abiomed Inc was delisted on Dec 22, 2022; its insiders filed their last Form 4 on Dec 27, 2022; 516 institutions reported holding it in 13F filings for Q3 2022, worth $10.6B in total; Maverick Capital was the only superinvestor holding it.

Holders of 5% or more of ABMD

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Abiomed Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Abiomed Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

11 Schedule 13D and 13G filings on Abiomed Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ABMD
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jan 6, 2023Baillie Gifford & Co13G/AOld format–––SEC
Dec 29, 2022Millennium Management LLC13GOld format–New–SEC
Feb 9, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 2022Wellington Management Group LLP13GOld format–New–SEC
Jan 18, 2022Baillie Gifford & Co13G/AOld format–––SEC
Jan 10, 202212:54 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 16, 2021Sands Capital Management, LLC13GOld format–New–SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 10, 2021Renaissance Technologies LLC13G/AOld format–––SEC
Jan 28, 20215:55 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 20, 2021Baillie Gifford & Co13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Abiomed Inc shares.

No Form 144 notices for Abiomed Inc are on file.